FDA clears way for more versatile atherectomy device

Candace Stuart | | Cardiovascular Business | Vascular & Endovascular

The FDA issued clearance for the 4 Fr 1.25 Solid Diamondback 360 Peripheral Orbital Atherectomy System to treat patients with peripheral artery disease (PAD).

Cardiovascular Systems’ new percutaneous devices have two crown designs, a 1.25mm Solid Crown and a 1.25mm Micro Crown, and provide a smaller profile and a more flexible shaft, according to the company. Both designs are 4 Fr sheath compatible and will allow physicians to treat PAD patients below the knee through the groin or to treat the upper leg through the foot.

In March of 2014, the St. Paul, Minn.-based company received FDA clearance for 60cm atherectomy system to treat lesions in the lower leg. The agency gave the Diamondback Orbital Atherectomy System 510(k) clearance in 2007.

Candace Stuart, Contributor

Related Content

IVUS-guided PCI reduces risks in patients with diabetes
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients
Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage
IVL vs. RA for chronic total occlusion PCI: Key data cardiologists should know

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."